Lily Huang

Lily Huang is a seasoned finance professional with extensive experience in healthcare investing and executive leadership. Currently serving as the Chief Financial Officer at Curana Health since 2024, Lily previously held the position of Partner at New Enterprise Associates (NEA) from 2017 to December 2023, focusing on venture and growth-stage investments in healthcare services and IT. Lily co-founded Elion in 2023, an independent marketplace for healthcare technology decisions, and served on the boards of Vori Health, which aims to create an integrated care model for musculoskeletal needs, and Curana Health, dedicated to enhancing the quality of life for senior living residents. Prior roles include positions at TPG Capital in private equity and at Goldman Sachs and Morgan Stanley in investment banking and leveraged finance, respectively. Lily holds a BS in Finance from The Wharton School and a BA in Biology from the University of Pennsylvania.